Spruce Point Capital Management, LLC ("Spruce Point" or "we" or "us"), a New York-based investment management firm that focuses on forensic research and short-selling, today issued a detailed report ...

Spruce Point Capital Management issued a report entitled, “Pulling Back the Curtain on Procept,” that outlines why the firm believes and ...

The global BPH treatment market is expected to grow from USD 33,031.10 million in 2024 to USD 47,045.80 million by 2034, at a ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

PRNewswire Bangalore Karnataka [India] January 15 Manipal Hospitals Sarjapur Road recently hosted an awareness session on ...

Manipal Hospitals Sarjapur Road hosted a session on HoLEP for Benign Prostatic Hyperplasia. This innovative technique, led by ...

Dr. Niti Navanimitkul, MD, from the Urology Center at Bangkok Hospital Pattaya gave an informative presentation to the Pattaya City Expats Club on Wednesday, January 8, about prostate health, focusing ...

Winter leads to an increased risk of problems related to the prostate gland in seniors. Cold weather causes urinary and ...

We are excited to reach this important milestone in the Expander-2 Pivotal Trial,” said Paul Edwards, President and CEO of Prodeon Medical. “Completing enrollment is a key step in our mission to ...

Annual check-ups save lives by detecting prostate issues early, yet many men avoid these crucial tests due to fear or misconceptions. Prostate health ...